123 related articles for article (PubMed ID: 31232234)
21. Lectin BS-I inhibits cell migration and invasion via AKT/GSK-3β/β-catenin pathway in hepatocellular carcinoma.
Jian Q; Yang Z; Shu J; Liu X; Zhang J; Li Z
J Cell Mol Med; 2018 Jan; 22(1):315-329. PubMed ID: 28922551
[TBL] [Abstract][Full Text] [Related]
22. Targeting Clusterin Induces Apoptosis, Reduces Growth Ability and Invasion and Mediates Sensitivity to Chemotherapy in Human Osteosarcoma Cells.
Wang X; Yu Y; Zang L; Zhang P; Ma J; Chen D
Curr Pharm Biotechnol; 2020; 21(2):131-139. PubMed ID: 31433751
[TBL] [Abstract][Full Text] [Related]
23. RBMY, a novel inhibitor of glycogen synthase kinase 3β, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma.
Chua HH; Tsuei DJ; Lee PH; Jeng YM; Lu J; Wu JF; Su DS; Chen YH; Chien CS; Kao PC; Lee CN; Hu RH; Ni YH; Chang MH
Hepatology; 2015 Nov; 62(5):1480-96. PubMed ID: 26185016
[TBL] [Abstract][Full Text] [Related]
24. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Lu WJ; Chua MS; Wei W; So SK
Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
[TBL] [Abstract][Full Text] [Related]
25. FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT/GSK-3β - dependent manner in hepatocellular carcinoma.
Yang W; Wu Y; Wang C; Liu Z; Xu M; Zheng X
Cancer Biomark; 2017 Jul; 20(1):75-85. PubMed ID: 28655132
[TBL] [Abstract][Full Text] [Related]
26. Down-regulating glypican-3 expression: molecular-targeted therapy for hepatocellular carcinoma.
Dong Z; Yao M; Wang L; Yang J; Yao D
Mini Rev Med Chem; 2014; 14(14):1183-93. PubMed ID: 25553423
[TBL] [Abstract][Full Text] [Related]
27. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
[TBL] [Abstract][Full Text] [Related]
28. Higher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin β1/GSK3β/β-Catenin Signaling Pathway.
You Y; Zheng Q; Dong Y; Wang Y; Zhang L; Xue T; Xie X; Hu C; Wang Z; Chen R; Wang Y; Cui J; Ren Z
PLoS One; 2015; 10(8):e0134243. PubMed ID: 26280346
[TBL] [Abstract][Full Text] [Related]
29. Chemosensitization of gemcitabine-resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin.
Muramaki M; So A; Hayashi N; Sowery R; Miyake H; Fujisawa M; Gleave ME
BJU Int; 2009 Feb; 103(3):384-90. PubMed ID: 19007378
[TBL] [Abstract][Full Text] [Related]
30. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.
Fan W; Du F; Liu X
Eur J Pharmacol; 2019 May; 850():109-117. PubMed ID: 30710548
[TBL] [Abstract][Full Text] [Related]
31. Far-infrared radiation inhibits proliferation, migration, and angiogenesis of human umbilical vein endothelial cells by suppressing secretory clusterin levels.
Hwang S; Lee DH; Lee IK; Park YM; Jo I
Cancer Lett; 2014 Apr; 346(1):74-83. PubMed ID: 24334140
[TBL] [Abstract][Full Text] [Related]
32. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
33. Secretory clusterin is upregulated in rats with pulmonary arterial hypertension induced by systemic-to-pulmonary shunts and exerts important roles in pulmonary artery smooth muscle cells.
Liu X; Meng L; Li J; Meng J; Teng X; Gu H; Hu S; Wei Y
Acta Physiol (Oxf); 2015 Feb; 213(2):505-18. PubMed ID: 25069740
[TBL] [Abstract][Full Text] [Related]
34. A novel mechanism of hepatocellular carcinoma cell apoptosis induced by lupeol via Brain-Derived Neurotrophic Factor Inhibition and Glycogen Synthase Kinase 3 beta reactivation.
Zhang L; Tu Y; He W; Peng Y; Qiu Z
Eur J Pharmacol; 2015 Sep; 762():55-62. PubMed ID: 26004524
[TBL] [Abstract][Full Text] [Related]
35. [Long noncoding RNA UFC1 promotes metastasis and invasion of hepatocellular carcinoma cells
Wang J; Cao C; Zeng Q; Dong Z
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):679-684. PubMed ID: 31270046
[TBL] [Abstract][Full Text] [Related]
36. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
[TBL] [Abstract][Full Text] [Related]
37. SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation.
Liu H; Hu J; Wei R; Zhou L; Pan H; Zhu H; Huang M; Luo J; Xu W
J Exp Clin Cancer Res; 2018 Sep; 37(1):229. PubMed ID: 30249289
[TBL] [Abstract][Full Text] [Related]
38. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
39. Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma.
Cervello M; Augello G; Cusimano A; Emma MR; Balasus D; Azzolina A; McCubrey JA; Montalto G
Adv Biol Regul; 2017 Aug; 65():59-76. PubMed ID: 28619606
[TBL] [Abstract][Full Text] [Related]
40. Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway.
Ng L; Chow AKM; Man JHW; Yau TCC; Wan TMH; Iyer DN; Kwan VHT; Poon RTP; Pang RWC; Law WL
BMC Cancer; 2018 Jun; 18(1):621. PubMed ID: 29859044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]